Registration | Schedule | Call for Abstracts | Hotel & Travel | Sponsor/Exhibit | Event Policies

  May 2 | May 3 | May 4 | May 5 | May 6 | May 7

2022 AAOM Schedule | Day 5 | Friday, May 6

Registration Desk Hours: 7:00 AM – 5:00 PM | East Mezzanine
Exhibitor Hours: 7:00 AM – 5:00 PM | Peabody Grand Ballroom C

Time Session Room
7:00 – 8:00 AM Continental Breakfast Peabody Grand Ballroom D–F
7:00 – 8:00 AM President's Breakfast Cockrell Room
8:00 – 9:30 PM The World Workshop on Oral Medicine Peabody Grand Ballroom A–B
9:30 – 10:00 AM Morning Break Peabody Grand Ballroom Foyer West
10:00 – 11:00 AM Jonathan Ship Lecture: The Intersection of Decision-Making in our Lives as Humans and Healthcare Practitioners
Craig Miller, DMD

This talk reviews the core principles of ethical decision-making in healthcare and emphasizes how ethical decision-making can be used to approach ethical dilemmas in healthcare practice.

Learning Objectives:

  1. Understand the decision-making process.
  2. Recognize the individual and collective factors that influence decision-making.
  3. Appreciate how to utilize “decision-hygiene” to minimize biases and noise.
 Peabody Grand Ballroom A–B
11:00 – 12:00 PM OTOD Session: Resident Case Reports
OTOD Committee		 Peabody Grand Ballroom A–B
12:00 – 1:30 PM Product Theater
Sponsored		 Continental Ballroom
12:00 – 1:30 PM Lunch on your own  
12:00 – 1:00 PM Quad O Lunch Cockrell Room
1:30 – 3:00 PM Plenary II: Combating Cancer Mortality: A sneak peek into the future of cancer detection
Moderators: Dr. Arwa Farag and Dr. Chelsia Sim		 Peabody Grand Ballroom A–B

 

 
1:30 – 1:55 PM Methylation-based Multi-Cancer Early Detection 
Eric A. Klein, MD

The multi-cancer early detection (MCED) is an innovative test used to complement existing screening modalities. This promising approach may increase the chance of detecting cancers at early stages, through population screening, and potentially improve disease-related outcomes.

Learning objectives:

  1. Demonstrate the scientific bases for multi-cancer early detection (MCED) test.
  2. Display the evidence-based multi-center investigations that explored and validated the prediction accuracy of MCED.
  3. Discuss the future utilization of MCED and how it may complement the existing single-cancer screening tests to reduced cancer-related mortality
1:55 – 2:20 PM

Early Detection of OSCC and OPMD: What Lies in the Epithelium and Beyond? 
Sook-Bin Woo, MD

This talk sheds light on investigational modalities that may assist in detection of oral squamous cell carcinoma (OSCC) and oral potentially malignant disorders (OPMDs) such as DNA-image cytometry (DNA-ICM), quantitative tissue phenotype (QTP), quantitative cytometric analysis, spectroscopy, and circulating miRNAs.

Learning objectives:

  1. Familiarize with the current investigational modalities that may assist in detection of oral squamous cell carcinoma (OSCC) and oral potentially malignant disorders (OPMDs).
  2. Provide an update for the potential phenotypic and genotypic markers that may help detect malignancies or predict the risk for malignant transformation.
  3. Identify the barriers and facilitators for utilizing these detection modalities in both research and clinical practice.
2:20 – 2:45 PM

Oral Potentially Malignant Disorders: Future Insights on Risk Assessment and Stratification
Saman Warnakulasuriya, BDS, FDSRCS (Eng), FDSRCS (Edin), FDSRCPS. (Glasg), PhD(Glasg), DSc, FKC

Oral potentially malignant disorders (OPMDs) are associated with an increased risk of oral/lip cancers transformation. This talk highlights the risk factors tied to OPMDs malignant transformation based on data from longitudinal observational investigations. It also discusses the pivotal need to develop a risk assessment and stratification tool that may optimize oral cancer surveillance.

Learning objectives:

  1. Familiarize with the updated OPMDs nomenclature and classification based on the recent World Health Organization (WHO) Collaborating Centre for Oral Cancer workshop.
  2. Appreciate the risk factors tied to OPMDs malignant transformation based on data from longitudinal observational investigations.
  3. Appreciate the pivotal need to develop a risk assessment/stratification tool that may optimize oral cancer surveillance. 
2:45 – 3:00 PM Plenary 2: Panel Discussion
3:00 – 3:30 PM Afternoon Break Peabody Grand Ballroom Foyer West
3:30 – 5:00 PM Oral Abstracts
OTOD Committee		 Peabody Grand Ballroom A–B
6:00 – 7:00 PM Oral Medicine Residents and New Graduates Meeting: Facing the Future – Together

Residents/PDC Committee
 Jackson Room
7:00 – 10:00 PM Presidents Awards Banquet Peabody Rooftop & Skyway

 

< Previous Day
Next Day >


May 2 | May 3 | May 4 | May 5 | May 6 | May 7